These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8915820)

  • 21. The structure, biology and potential therapeutic applications of recombinant thrombopoietin.
    Lok S; Foster DC
    Stem Cells; 1994 Nov; 12(6):586-98. PubMed ID: 7881359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombopoietin: its role from early hematopoiesis to platelet production.
    Wendling F
    Haematologica; 1999 Feb; 84(2):158-66. PubMed ID: 10091415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of platelet growth factors in cancer therapy.
    Clarke K; Basser RL
    Stem Cells; 1996; 14 Suppl 1():274-80. PubMed ID: 11012231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Do the preclinical effects of thrombopoietin correlate with its in vitro properties?
    Kaushansky K; Broudy VC; Sitnicka E; Lofton-Day C; Grossmann A; Sprugel K
    Stem Cells; 1996; 14 Suppl 1():108-11. PubMed ID: 11012209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
    Newland A
    Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thrombopoietic growth factor--thrombopoietin. Molecular and biological properties].
    Skotnicki AB; Jabłoński MJ
    Przegl Lek; 1996; 53(11):826-9. PubMed ID: 9173448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biology of thrombopoietin and its receptors].
    Robak T
    Postepy Hig Med Dosw; 1996; 50(6):649-63. PubMed ID: 9064684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombopoietin (Mpl-ligand) and the regulation of platelet production.
    Cohen-Solal K; Debili N; Vainchenker W; Wendling F
    Thromb Haemost; 1997 Jul; 78(1):37-41. PubMed ID: 9198124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombopoietin: biology and potential clinical applications.
    Prow D; Vadhan-Raj S
    Oncology (Williston Park); 1998 Nov; 12(11):1597-604, 1607-8; discussion 1611-4. PubMed ID: 9834938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical studies with megakaryocyte growth and development factor (Mpl-ligand).
    Begley CG
    Thromb Haemost; 1997 Jul; 78(1):42-6. PubMed ID: 9198125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
    Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
    Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early Australian clinical studies with pegylated recombinant human megakaryocyte growth and development factor.
    Basser RL
    Stem Cells; 1998; 16 Suppl 2():225-9. PubMed ID: 11012194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombopoietin, a direct stimulator of viability and multilineage growth of primitive bone marrow progenitor cells.
    Jacobsen SE; Borge OJ; Ramsfjell V; Cui L; Cardier JE; Veiby OP; Murphy MJ; Lok S
    Stem Cells; 1996; 14 Suppl 1():173-80. PubMed ID: 11012218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Mpl ligands on platelet production and function in nonhuman primates.
    Harker LA; Marzec UM; Kelly AB
    Stem Cells; 1998; 16 Suppl 2():107-19. PubMed ID: 11012183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiologic role of TPO in thrombopoiesis.
    Miyazaki H
    Stem Cells; 1996; 14 Suppl 1():133-8. PubMed ID: 11012213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of PEG-rhuMGDF in platelet apheresis.
    Kuter DJ
    Stem Cells; 1998; 16 Suppl 2():231-42. PubMed ID: 11012195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Native thrombopoietin: structure and function.
    Kato T; Matsumoto A; Ogami K; Tahara T; Morita H; Miyazaki H
    Stem Cells; 1998; 16(5):322-8. PubMed ID: 9766811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic deficiencies in c-mpl and TPO knockout mice.
    Murone M; Carpenter DA; de Sauvage FJ
    Stem Cells; 1998; 16(1):1-6. PubMed ID: 9474742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of recombinant interleukin 11 in megakaryocytopoiesis.
    Turner KJ; Neben S; Weich N; Schaub RG; Goldman SJ
    Stem Cells; 1996; 14 Suppl 1():53-61. PubMed ID: 11012203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Megakaryocytic growth factors: is there a new approach for management of thrombocytopenia in patients with malignancies?
    Hofmann WK; Ottmann OG; Hoelzer D
    Leukemia; 1999 Jan; 13(1):14-8. PubMed ID: 10049050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.